CompletedNot Applicable

Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant

Egypt30 participantsStarted 2023-06-22

Plain-language summary

the purpose of this trial is to evaluate the osseointegration properties of nano-hydroxy apatite coated titanium implants in posterior maxilla. 30 patients will be included in this trial divided into two groups, control and intervention. Primary and secondary implant stability will be measured

Who can participate

Age range18 Years – 49 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with missing at least one maxillary posterior tooth
✓. Patients free from any systemic disease
✓. Patients who approve to be included in the trial and sign the informed consent
✓. Patients with no intra-bony defect.
✓. Adults aged 18 years old and above

Exclusion criteria

✕. Patients who are allergic to titanium
✕. Heavy smoker patient
✕. Patients receiving chemotherapy or radiotherapy
✕. Patients who refused to be included in the trial

What they're measuring

Implant stability

Timeframe: immediately post-operative

Implant stability

Timeframe: 4 weeks post-operative

Implant stability

Timeframe: 6 weeks post-operative

Implant stability

Timeframe: 12 weeks post-operative

Trial details

NCT IDNCT05936775

SponsorOctober University for Modern Sciences and Arts

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-01

View on ClinicalTrials.gov More Implant Site Reaction trials